NCT04305496 2026-04-30CAPItello-291AstraZenecaPhase 3 Active not recruiting818 enrolled 19 charts 2 FDA
NCT04191499 2026-03-17INAVO120Hoffmann-La RochePhase 2/3 Active not recruiting325 enrolled 14 charts 1 FDA
NCT04975308 2025-07-11EMBER-3Eli Lilly and CompanyPhase 3 Active not recruiting874 enrolled 29 charts 1 FDA